Is Broncho-Vaxom effective?

There are no recommendations indicating the appropriateness of conducting any blood tests before or after treatment with Broncho-Vaxom to assess its efficacy. The results of treatment with the broncho-Vaxom bacterial vaccine in a patient can only be assessed by assessing whether the incidence of upper respiratory tract infections has decreased. The Broncho-Vaxom vaccine contains killed bacteria or fragments of bacteria that most commonly cause upper respiratory tract infections. These preparations administered orally cause activation of lymphoid tissue in the gastrointestinal tract and the formation of antibodies that protect the body against these microorganisms. The effectiveness of this type of preparations has been confirmed in numerous clinical trials, which have shown that bacterial vaccines reduce the frequency of recurrence of infections, shorten their duration and reduce the frequency of antibiotic therapy. One meta-analysis, conducted in 2012, showed that bacterial vaccines compared to placebo reduced the incidence of respiratory tract infections by 41%. It was also noted that the effectiveness of therapy is the higher, the greater the patient's susceptibility to infections. You can read more about bacterial vaccines in the text: https://www.gdziepolek.pl/kategorie/nieswoiste-szczepionki-bakteryjne